EGFR mutation testing in nonsmall cell lung cancer patients by using cytology specimens: When the tissue is no longer the issue

Cancer Cytopathology

Volumn 119, Issue 5, 2011, Pages 354-

  Gil Bazo, Ignacio ^a   Castanón, Eduardo ^a   Fusco, Juan P ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ERLOTINIB; GEFITINIB; PROTEIN TYROSINE KINASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; RAS PROTEIN;

ADVANCED CANCER; CYTOLOGY; ENDOBRONCHIAL ULTRASONOGRAPHY; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE BIOPSY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; MUTATIONAL ANALYSIS; PHARMACOGENETICS; PREDICTIVE VALUE; PRIORITY JOURNAL; FEMALE; GENETICS; LUNG TUMOR; MALE; MUTATION; NOTE;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84856382169     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20183     Document Type: Letter

References (4)

1. Billah S, Stewart J, Staerkel G, Chen S, Gong Y, Guo M. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens. Cancer Cytopathol. 2011;119:111-117.
2. Keedy VL, Temin S, Somerfield MR, et al. American Society of Clinical Oncology Provisional Clinical Opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced nonsmall-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol. 2011;29:2121-2127.
3. Pirker R, Herth FJ, Kerr KM, et al European EGFR Workshop Group. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol. 2010;5:1706-1713.
4. Lozano MD, Gurpide A, Echeveste JI, et al. Assessment of epidermal growth factor receptor (EGFR) and K-ras mutation status in cytologic stained smears of non-small cell lung cancer (NSCLC) patients. J Clin Oncol. 2010;28(Suppl):7560.